TP53 and neoplasm: A commercial dPCR probe targeting a somatic single nucleotide variant (SNV) in the TP53 gene (TP53:c.734G>T:p.G245V), identified through whole-exome sequencing of the tumor and absent in genomic DNA, was chosen to monitor early recurrence during the post-surgical follow-up.